<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="63a2a6d4-f197-4a58-aa85-2ad5ecfb50b6"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>These highlights do not include all the information needed to use ABLYSINOL 
 <sup>Â®</sup> safely and effectively. See full prescribing information for ABLYSINOL.
 <br/>
      <br/>
ABLYSINOL (dehydrated alcohol) injection, for cardiac septal branch intra-arterial use
 <br/>
      <br/>
Initial U.S. Approval: 1946
</title>
   <effectiveTime value="20250313"/>
   <setId root="314b1dab-8f4f-49ae-a105-f974842818b8"/>
   <versionNumber value="10"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id root="1.3.6.1.4.1.519.1" extension="078627620"/>
            <name>BPI Labs, LLC</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id root="1.3.6.1.4.1.519.1" extension="480601586"/>
                        <name>Sintetica SA</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C25391" displayName="analysis" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="54288-105" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
                  <assignedEntity>
                     <assignedOrganization>
                        <id root="1.3.6.1.4.1.519.1" extension="480895478"/>
                        <name>Sintetica SA</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" displayName="manufacture" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="54288-105" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" displayName="analysis" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="54288-105" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84732" displayName="label" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="54288-105" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" displayName="pack" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="54288-105" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
                  <assignedEntity>
                     <assignedOrganization>
                        <id root="1.3.6.1.4.1.519.1" extension="078627620"/>
                        <name>BPI Labs LLC</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" displayName="manufacture" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="54288-144" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" displayName="analysis" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="54288-144" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84732" displayName="label" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="54288-144" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="03877b67-83c6-46f6-9367-614d3be7daf5"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <effectiveTime value="20250313"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="54288-105" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Dehydrated Alcohol</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Alcohol</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mL" value="1"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="3K9958V90M" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ALCOHOL</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="3K9958V90M" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ALCOHOL</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="54288-105-01" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43165" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="AMPULE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="10" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="54288-105-10" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20181024"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                        <asContent>
                           <quantity>
                              <numerator value="5" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="54288-105-02" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43165" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="AMPULE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="10" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="54288-105-15" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20181024"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA207987" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20181024"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38676" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PERCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="54288-144" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Dehydrated Alcohol</name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Alcohol</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mL" value="1"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="3K9958V90M" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ALCOHOL</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="3K9958V90M" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>ALCOHOL</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="5" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="54288-144-01" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43215" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="VIAL, SINGLE-DOSE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="10" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="54288-144-10" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20250401"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="NDA207987" root="2.16.840.1.113883.3.150"/>
                           <code code="C73594" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20250401"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38676" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PERCUTANEOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="Lcbe06238-854c-40fd-88a3-7b6a3e3b0a86">
               <id root="1ce32778-fdc7-40dd-acaa-eb0ab2ebe3ee"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>1 INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>ABLYSINOL
       
 
  <sup>Â®</sup> is indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy who are not candidates for surgical myectomy.
      

 </paragraph>
               </text>
               <effectiveTime value="20250317"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>ABLYSINOL is an ablative agent indicated to induce controlled cardiac septal infarction to improve exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy who are not candidates for surgical myectomy. ( <linkHtml href="#Lcbe06238-854c-40fd-88a3-7b6a3e3b0a86">1</linkHtml>)</paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="L616cab07-f86f-4158-8365-fc3db3236ac5">
               <id root="b7b4520e-fd75-3e3f-e053-2a95a90ab4ba"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>2 DOSAGE AND ADMINISTRATION</title>
               <text/>
               <effectiveTime value="20181018"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>Inject small volumes over 1 to 2 minutes percutaneously into septal arterial branches, using the minimal dose necessary to achieve the desired reduction in peak left ventricular outflow tract pressure gradient. (
          
  
     <linkHtml href="#L3c317eab-692e-451b-baf3-afeff378fd83">2.1</linkHtml>)
 
    </item>
                           <item>In most situations, a dose of 1 mL to 2 mL is sufficient. The maximum dose that should be used in a single procedure is 5 mL. (
          
  
     <linkHtml href="#L3c317eab-692e-451b-baf3-afeff378fd83">2.1</linkHtml>)
 
    </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="L3c317eab-692e-451b-baf3-afeff378fd83">
                     <id root="b7b4520e-fd76-3e3f-e053-2a95a90ab4ba"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.1 Recommended Dosing</title>
                     <text>
                        <paragraph>Use the minimum dose necessary to achieve the desired reduction in peak left ventricular outflow tract pressure gradient. Inject small volumes over 1 to 2 minutes percutaneously into septal arterial branches, guided by assessment of the gradient. In most situations, a dose of 1 mL to 2 mL is sufficient. The maximum dose of ABLYSINOL that should be used in a single procedure is 5 mL.</paragraph>
                     </text>
                     <effectiveTime value="20181017"/>
                  </section>
               </component>
               <component>
                  <section ID="L86b86834-77c1-4b79-9eaf-486223eb8c2a">
                     <id root="b7b4520e-fd77-3e3f-e053-2a95a90ab4ba"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>2.2 Administration</title>
                     <text>
                        <paragraph>ABLYSINOL should only be administered under the supervision of a qualified interventional cardiologist experienced in the percutaneous transluminal septal myocardial ablation procedure.</paragraph>
                        <paragraph>Inspect visually for particulate matter and discoloration prior to administration. ABLYSINOL should appear as a clear, colorless solution.</paragraph>
                     </text>
                     <effectiveTime value="20181017"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="L70cf74c9-6e93-473c-affc-7a452ba7da84">
               <id root="d9091876-c1cf-48f5-bdac-c96032e6d152"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE FORMS &amp; STRENGTHS SECTION"/>
               <title>3 DOSAGE FORMS AND STRENGTHS</title>
               <text>
                  <paragraph>Injection: 1 mL or 5 mL of ethyl alcohol â¥ 99% by volume as a clear, colorless liquid in a single-dose glass ampule.</paragraph>
                  <paragraph>Injection: 5 mL of ethyl alcohol â¥ 99% by volume as a clear, colorless liquid in a single-dose glass vial.</paragraph>
               </text>
               <effectiveTime value="20250313"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>Injection: 1 mL or 5 mL of ethyl alcohol â¥ 99% by volume as a clear, colorless liquid in a single-dose glass ampule. ( <linkHtml href="#L70cf74c9-6e93-473c-affc-7a452ba7da84">3</linkHtml>)</item>
                           <item>Injection: 5 mL of ethyl alcohol â¥ 99% by volume as a clear, colorless liquid in a single-dose glass vial. (3)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="Lb1e79b67-c89f-4675-a374-c62f8aba1e83">
               <id root="23197889-c055-44ab-bf96-bee8a2788fbd"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>4 CONTRAINDICATIONS</title>
               <text>
                  <paragraph>None.</paragraph>
               </text>
               <effectiveTime value="20250317"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>None ( <linkHtml href="#Lb1e79b67-c89f-4675-a374-c62f8aba1e83">4</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="L5b00b6a9-fd33-49cb-b293-b20ee80bb55e">
               <id root="b8996198-2261-421c-808d-df6a12c701c4"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS AND PRECAUTIONS SECTION"/>
               <title>5 WARNINGS AND PRECAUTIONS</title>
               <text/>
               <effectiveTime value="20250317"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>Transient heart block: Transient heart block is common at the time of injection. A temporary pacing wire is routinely inserted to mitigate transient heart block. (5.1)</item>
                           <item>Persistent heart block: Approximately 10% of complete heart block events become permanent and require placement of a permanent pacemaker. (5.1)</item>
                           <item>Remove the temporary pacemaker lead if no episode of high-degree atrioventricular block occurs. (5.1)</item>
                           <item>Monitor the patient for heart failure, chest pain, and arrhythmias several days after the procedure. (5.1, 
          
  
     <linkHtml href="#L8261a921-76e3-435a-8f88-89c21a6b8b7d">5.2</linkHtml>, 
          
  
     <linkHtml href="#L46e09f37-4952-470b-915d-1b4f4611a3c5">5.3</linkHtml>)
         
 
    </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="L0a06e585-7c38-46b9-a090-8094d61599f1">
                     <id root="d7f30737-8c7c-4f1c-a42d-7a3e04bc93ec"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.1 Heart Block</title>
                     <text>
                        <paragraph>
                           <content styleCode="italics">Transient Heart Block</content>
                           <br/>Transient heart block is common at the time of dehydrated alcohol, such as ABLYSINOL, injection into a septal artery. Prior to the injection, a temporary pacing wire is routinely inserted into the apex of the right ventricle, usually via the femoral vein, to treat transient heart block. The pacing lead can be removed if no episode of high-degree atrioventricular block occurs, usually after several hours of observation following percutaneous transluminal septal myocardial ablation.</paragraph>
                        <paragraph>
                           <content styleCode="italics">Persistent Heart Block</content>
                           <br/>Approximately 10% of complete heart block events become permanent and require placement of a permanent pacemaker following percutaneous transluminal septal myocardial ablation. Risk factors for permanent pacemaker dependency after septal ablation include a baseline PQ interval &gt; 160 ms, baseline minimum heart rate &lt; 50 bpm, baseline left ventricular outflow gradient &gt; 70 mmHg, maximum QRS during the first 48 hours &gt; 155 ms, 3<sup>rd</sup> degree atrio-ventricular block occurring during the procedure, and no clinical recovery between 12-48 hours after the procedure.</paragraph>
                     </text>
                     <effectiveTime value="20250317"/>
                  </section>
               </component>
               <component>
                  <section ID="L8261a921-76e3-435a-8f88-89c21a6b8b7d">
                     <id root="ae669467-e5c4-4a06-8c3a-521603671ca2"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.2 Myocardial Infarction
        

 <content styleCode="bold"/>
                     </title>
                     <text>
                        <paragraph>Injection of dehydrated alcohol is intended to create a controlled myocardial infarction for therapeutic purposes. However, excessive myocardial necrosis and subsequent heart failure have been reported. Factors increasing the risk of excessive tissue necrosis include higher volume of alcohol used and a higher number of septal branches injected to reduce the left ventricular outflow tract gradient.</paragraph>
                     </text>
                     <effectiveTime value="20250317"/>
                  </section>
               </component>
               <component>
                  <section ID="L46e09f37-4952-470b-915d-1b4f4611a3c5">
                     <id root="b7b4520e-fd7d-3e3f-e053-2a95a90ab4ba"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>5.3 Ventricular Arrhythmia</title>
                     <text>
                        <paragraph>Ventricular tachycardia and ventricular fibrillation requiring electrocardioversion occurred at a frequency of approximately 1%. Perform continuous electrocardiographic monitoring for 48 hours after the procedure.</paragraph>
                     </text>
                     <effectiveTime value="20181017"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="L5ad00975-5216-4dc7-bfe9-284b4fae7217">
               <id root="0ccea772-33ed-4262-9ccf-d83a766c00ef"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>6 ADVERSE REACTIONS</title>
               <text>
                  <paragraph>Heart block [
       
 
  <content styleCode="italics">see Warnings and precautions</content> (5.1)]
      

 </paragraph>
                  <paragraph>The following other adverse reactions associated with percutaneous transluminal septal myocardial ablation with the use of dehydrated alcohol, such as ABLYSINOL, were identified in the literature: Ventricular tachycardia and ventricular fibrillation.</paragraph>
               </text>
               <effectiveTime value="20250317"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Adverse reactions include arrhythmias, including ventricular tachycardia and/or ventricular fibrillation. ( <linkHtml href="#L5ad00975-5216-4dc7-bfe9-284b4fae7217">6</linkHtml>)</paragraph>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact BPI Labs, LLC at (727) 471-0850 or FDA at 1-800-FDA-1088 orÂ </content>
                           <content styleCode="bold">
                              <content styleCode="italics">www.fda.gov/medwatch.</content>
                           </content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="L38d5deb3-5056-4a81-801a-8dbf782d647a">
               <id root="b7b4520e-fd7f-3e3f-e053-2a95a90ab4ba"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="USE IN SPECIFIC POPULATIONS SECTION"/>
               <title>8 USE IN SPECIFIC POPULATIONS</title>
               <text/>
               <effectiveTime value="20181018"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered">
                           <item>ABLYSINOL is not recommended during pregnancy. Maternal use is not expected to result in fetal exposure to the drug. (
          
  
     <linkHtml href="#L136103a0-f528-4371-a43c-f0ec5be0bef8">8.1</linkHtml>)
         
 
    </item>
                           <item>The rate of heart blocks and dysrhythmia increased with age. (8.5)</item>
                        </list>
                        <paragraph>
                           <content styleCode="bold">See 17 for PATIENT COUNSELING INFORMATION</content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="L136103a0-f528-4371-a43c-f0ec5be0bef8">
                     <id root="b7b4520e-fd80-3e3f-e053-2a95a90ab4ba"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>8.1 Pregnancy</title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Risk Summary</content>
                           <br/>The concentrations of alcohol in blood after PTSMA were not measured, but ABLYSINOL is not expected to increase significantly the systemic concentrations of endogenous alcohol following administration into a septal artery during percutaneous transluminal septal myocardial ablation. Maternal use is not expected to result in fetal exposure to the drug.
        

 </paragraph>
                        <paragraph>
                           <content styleCode="underline">Clinical Considerations</content>
                           <br/>ABLYSINOL for percutaneous transluminal septal myocardial ablation has not been evaluated in pregnant women and is not recommended during pregnancy. When possible, the percutaneous transluminal septal myocardial ablation procedure should be postponed in women until the postpartum period.
        

 </paragraph>
                        <paragraph>
                           <content styleCode="underline">Data</content>
                           <br/>Animal reproduction studies have shown an adverse effect on the fetus and chronic fetal alcohol exposure is known to cause developmental defects in human. The developmental effects of acute ethanol exposure, such as from percutaneous transluminal septal myocardial ablation, have not been studied in pregnant or lactating women.
        

 </paragraph>
                     </text>
                     <effectiveTime value="20181017"/>
                  </section>
               </component>
               <component>
                  <section ID="L4e5e430a-10ac-4c17-a12c-c933a1374182">
                     <id root="b7b4520e-fd81-3e3f-e053-2a95a90ab4ba"/>
                     <code code="77290-5" codeSystem="2.16.840.1.113883.6.1" displayName="LACTATION SECTION"/>
                     <title>8.2 Lactation</title>
                     <text>
                        <paragraph>ABLYSINOL is not expected to increase significantly the systemic concentrations of endogenous alcohol following administration into a septal artery during percutaneous transluminal septal myocardial ablation and breastfeeding is not expected to result in exposure of the child to the drug.</paragraph>
                     </text>
                     <effectiveTime value="20181017"/>
                  </section>
               </component>
               <component>
                  <section ID="L4a439c8f-04a4-4f69-9481-11aaba0f8fb5">
                     <id root="b7b4520e-fd82-3e3f-e053-2a95a90ab4ba"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>8.4 Pediatric Use</title>
                     <text>
                        <paragraph>Safety and effectiveness in pediatric patients have not been established.</paragraph>
                     </text>
                     <effectiveTime value="20181017"/>
                  </section>
               </component>
               <component>
                  <section ID="L07860b8b-621f-4119-b3e1-66072a6b4432">
                     <id root="b7b4520e-fd83-3e3f-e053-2a95a90ab4ba"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="GERIATRIC USE SECTION"/>
                     <title>8.5 Geriatric Use</title>
                     <text>
                        <paragraph>A comparison of the outcomes in patients with hypertrophic obstructive cardiomyopathy in patients &lt; 60 years old and in patients â¥ 60 years old showed similar improvement in exercise capacity after ablation. The rate of heart blocks and dysrhythmia increased with age. Permanent pacemaker dependency increased to 34% in patients &gt; 60 years old.</paragraph>
                     </text>
                     <effectiveTime value="20181017"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="L3fecd321-19fa-4155-90ba-881ab36539c6">
               <id root="b7b4520e-fd84-3e3f-e053-2a95a90ab4ba"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>10 OVERDOSAGE</title>
               <text>
                  <paragraph>There is a direct correlation between the volume of alcohol and size of iatrogenic myocardial infarction. Stop the procedure if there is failure to reduce the left ventricular outflow tract pressure gradient to less than 10 mmHg when reaching a total dose of 5 mL.</paragraph>
               </text>
               <effectiveTime value="20181017"/>
            </section>
         </component>
         <component>
            <section ID="Le247a2c9-d8dc-439b-aa9c-144696eec0fc">
               <id root="3ce08772-9643-433d-9813-fdd94428d28e"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>11 DESCRIPTION</title>
               <text>
                  <paragraph>ABLYSINOL (dehydrated alcohol) injection is a sterile, preservative free solution of â¥ 99% by volume ethyl alcohol and no excipients. ABLYSINOL is for cardiac septal branch intra-arterial use. It has a molecular formula of C<sub>2</sub>H<sub>6</sub>O and a molecular weight of 46.07.</paragraph>
                  <paragraph>Dehydrated Alcohol Injection, USP is a potent tissue toxin. Ethanol is a clear, colorless, volatile, and flammable liquid miscible with water. It has the following structural formula:</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="Lbb2998a1-02c4-4c97-82e9-ecec298e13cc"/>
                  </paragraph>
                  <paragraph/>
               </text>
               <effectiveTime value="20250317"/>
               <component>
                  <observationMedia ID="Lbb2998a1-02c4-4c97-82e9-ecec298e13cc">
                     <text>chemicalstructure</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="chemicalstructure.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="L1c209e88-cbfc-44da-a9c7-a2fc01a55af5">
               <id root="b7b4520e-fd86-3e3f-e053-2a95a90ab4ba"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>12 CLINICAL PHARMACOLOGY</title>
               <text/>
               <effectiveTime value="20181017"/>
               <component>
                  <section ID="L751c3e69-f02a-4478-bb36-784c8b9e323a">
                     <id root="b7b4520e-fd87-3e3f-e053-2a95a90ab4ba"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="MECHANISM OF ACTION SECTION"/>
                     <title>12.1 Mechanism of Action</title>
                     <text>
                        <paragraph>Dehydrated alcohol is a tissue toxin that produces a myocardial infarction when injected through an intra-arterial catheter into a target septal vessel, which causes the hypertrophied septum to thin.</paragraph>
                     </text>
                     <effectiveTime value="20181017"/>
                  </section>
               </component>
               <component>
                  <section ID="L0e8f5f43-bc8b-47a1-8da5-fd91bdc9c118">
                     <id root="b7b4520e-fd88-3e3f-e053-2a95a90ab4ba"/>
                     <code code="43681-6" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACODYNAMICS SECTION"/>
                     <title>12.2 Pharmacodynamics</title>
                     <text>
                        <paragraph>A dose independent, approximate 70% reduction of the peak pressure gradient across left ventricular outflow tract is observed after injection of alcohol volumes in the range of 1-4 mL. Remodeling contributes about 20% to the 70% total reduction in peak pressure gradient across the left ventricular outflow tract measured 12 months after septal ablation. Other markers, such as infarct size or peak concentration of creatine kinase-MB (CK-MB), in contrast to peak pressure gradient across the left ventricular outflow tract, vary in proportion to the injected alcohol volume in the 1-4 mL range.</paragraph>
                     </text>
                     <effectiveTime value="20181017"/>
                  </section>
               </component>
               <component>
                  <section ID="L39043555-5598-4d81-aa9e-c7ea373c97de">
                     <id root="b7b4520e-fd89-3e3f-e053-2a95a90ab4ba"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="PHARMACOKINETICS SECTION"/>
                     <title>12.3 Pharmacokinetics</title>
                     <text>
                        <paragraph>Because injection of ABLYSINOL during septal ablation is not expected to increase the systemic concentrations of endogenous alcohol significantly, the pharmacokinetics of dehydrated alcohol are not expected to be clinically significant.</paragraph>
                     </text>
                     <effectiveTime value="20181017"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="L8444a359-2184-4c20-ab13-4cea66c02614">
               <id root="393f002f-f33c-4aab-a3dc-50b61253a375"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="NONCLINICAL TOXICOLOGY SECTION"/>
               <title>13 NONCLINICAL TOXICOLOGY</title>
               <text/>
               <effectiveTime value="20250317"/>
               <component>
                  <section ID="Lb06c6551-1630-4fbf-9235-6883407305e2">
                     <id root="e28add9a-3887-442a-bc8a-2452a76775cc"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <paragraph>Ethanol (of alcohol beverages) was added to Group 1 International Agency for Research on Cancer (IARC) Carcinogenicity Ratings (IARC monographs). Substances in this group are either carcinogenic to humans, or there is sufficient evidence of carcinogenicity in experimental animals and strong evidence in exposed humans that the substance acts through a relevant mechanism of carcinogenicity. Alcohol consumption has been associated with various cancers, including liver, esophageal, breast, prostate, and colorectal cancer. Since ABLYSINOL is not expected to reach the systemic circulation following administration into a septal artery during percutaneous transluminal septal myocardial ablation, the recommended clinical use of the drug product is not expected to have carcinogenic risk in patients.</paragraph>
                        <paragraph>Literature reports suggest that ethanol is not mutagenic in the in vitro bacterial reverse mutation (Ames) assay or in vitro chromosomal aberration assays. Ethanol is metabolized to acetaldehyde, which is a known mutagen.</paragraph>
                        <paragraph>There are no data from either animal or human studies regarding potential for the impairment of fertility.</paragraph>
                     </text>
                     <effectiveTime value="20250317"/>
                  </section>
               </component>
               <component>
                  <section ID="L1b0fa500-8975-49ee-bc2d-a1379e05513a">
                     <id root="8eecee2f-a384-4ee7-aa5e-2453845cda49"/>
                     <code code="34091-9" codeSystem="2.16.840.1.113883.6.1" displayName="ANIMAL PHARMACOLOGY &amp; OR TOXICOLOGY SECTION"/>
                     <title>13.2 Animal Toxicology and/or Pharmacology</title>
                     <text>
                        <paragraph>The median lethal dose (LD<sub>50</sub>) values for ethyl alcohol given by intravenous and oral routes are 1440 and 7060 mg/kg in rats and 1973 and 3450 mg/kg in mice, respectively. The LD<sub>50</sub> for ethyl alcohol given by subcutaneous injection is 8285 mg/kg in mice.</paragraph>
                     </text>
                     <effectiveTime value="20250317"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="L3782237c-2e9a-4ba7-901b-5936444e776e">
               <id root="b7b4520e-fd8d-3e3f-e053-2a95a90ab4ba"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL STUDIES SECTION"/>
               <title>14 CLINICAL STUDIES</title>
               <text>
                  <paragraph>Evidence of the effectiveness of ethanol on exercise capacity in adults with symptomatic hypertrophic obstructive cardiomyopathy who are not candidates for surgical myectomy was obtained from literature involving over 4000 patients.</paragraph>
               </text>
               <effectiveTime value="20181017"/>
            </section>
         </component>
         <component>
            <section ID="Lc771a600-d1f4-4d81-9049-f1d82e9cdfd0">
               <id root="2c232fe1-98d6-4d30-97d9-a703471f3e40"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING</title>
               <text>
                  <paragraph>ABLYSINOL (dehydrated alcohol) injection is a clear, colorless liquid supplied in clear, glass, single-dose ampules and single-dose vials. Each mL contains 99% by volume ethyl alcohol.</paragraph>
                  <table width="100%">
                     <caption/>
                     <tbody>
                        <tr>
                           <td rowspan="2">
                              <content styleCode="bold">Volume</content>
                           </td>
                           <td colspan="2">
                              <content styleCode="bold">Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â NDC</content>
                           </td>
                        </tr>
                        <tr>
                           <td colspan="2"/>
                        </tr>
                        <tr>
                           <td/>
                           <td>
                              <content styleCode="bold">Single ampule</content>
                           </td>
                           <td>
                              <content styleCode="bold">Carton of 10 ampules</content>
                           </td>
                        </tr>
                        <tr>
                           <td>1 mL</td>
                           <td>54288-105-01</td>
                           <td>54288-105-10</td>
                        </tr>
                        <tr>
                           <td>5 mL</td>
                           <td>54288-105-02</td>
                           <td>54288-105-15</td>
                        </tr>
                        <tr>
                           <td/>
                           <td/>
                           <td/>
                        </tr>
                        <tr>
                           <td/>
                           <td>
                              <content styleCode="bold">Single Vial</content>
                           </td>
                           <td>
                              <content styleCode="bold">Â Carton of 10 Vials</content>
                           </td>
                        </tr>
                        <tr>
                           <td>5 mL</td>
                           <td>Â 54288-144-01</td>
                           <td>Â 54288-144-10</td>
                        </tr>
                     </tbody>
                  </table>
                  <paragraph/>
                  <paragraph/>
                  <paragraph>Store at room temperature, between 20Â°C and 25Â°C (68Â°F and 77Â°F). Do not refrigerate or freeze. Highly flammable, store away from any heat source.</paragraph>
               </text>
               <effectiveTime value="20250317"/>
            </section>
         </component>
         <component>
            <section ID="L142ac81d-3731-4351-832b-6c54452171bf">
               <id root="5b8c46cb-1473-47d9-9cd2-ddd86f05907f"/>
               <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
               <title/>
               <text>
                  <paragraph/>
                  <paragraph>
                     <content styleCode="bold">Ampules:Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â  Â Â </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Manufactured for:</content>
                  </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="L415ff4a0-1420-4dcf-ab81-7cc2e320d074"/>
                  </paragraph>
                  <paragraph>BPI Labs, LLC, Largo, FL 33773 USA</paragraph>
                  <paragraph>
                     <content styleCode="bold">Manufactured by:</content>
                     <br/>Sintetica SA <br/>Via Penate 5 <br/>6850 Mendrisio, Switzerland</paragraph>
                  <paragraph/>
                  <paragraph>
                     <content styleCode="bold">Vials:</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Manufactured by:</content>
                     <br/>BPI Labs, LLC<br/>12393 Belcher Rd S, Suite 450<br/>Largo, FL 33773</paragraph>
                  <paragraph/>
               </text>
               <effectiveTime value="20250317"/>
               <component>
                  <observationMedia ID="L415ff4a0-1420-4dcf-ab81-7cc2e320d074">
                     <text>BPIlogo</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="BPIlogo.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="L7c1d3855-d9c9-4610-a7f1-9c5770c1a1f9">
               <id root="bce13809-62a5-43fd-af45-2f336d7efea1"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 1 mL AMPULE</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">ABLYSINOLÂ® (Dehydrated Alcohol Injection, USP)</content>
                     <br/>
                     <br/>
                     <content styleCode="bold">NDC 54288-105-01</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">1 mL - AMPULE - LABEL</content>
                  </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="L2e5ffa1f-f4ce-4328-bae0-9893585684cb"/>
                  </paragraph>
                  <paragraph/>
                  <paragraph>
                     <content styleCode="bold">ABLYSINOLÂ® (Dehydrated Alcohol Injection, USP)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 54288-105-10</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">1 mL - AMPULE - CARTONÂ  - 10 PACK</content>
                  </paragraph>
                  <paragraph/>
                  <paragraph>
                     <renderMultiMedia referencedObject="L262ddd02-80a1-4520-a1ce-4ee92d6f8285"/>
                  </paragraph>
                  <paragraph/>
               </text>
               <effectiveTime value="20250317"/>
               <component>
                  <observationMedia ID="L2e5ffa1f-f4ce-4328-bae0-9893585684cb">
                     <text>1 mL Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Ablysinol_1ml_label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="L262ddd02-80a1-4520-a1ce-4ee92d6f8285">
                     <text>1 mL Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Ablysinol_1ml_carton.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="L298742ba-5d60-47a7-a84d-7305580cbd1a">
               <id root="005fcba8-11e2-41b3-a34c-ed2a11c51663"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 5 mL AMPULE</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">ABLYSINOLÂ® (Dehydrated Alcohol Injection, USP)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content>NDC 54288-105-02</content>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">5mL - AMPULE - LABEL</content>
                  </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="La439e64f-120d-41f9-ae7a-ea67c5c19fc1"/>
                  </paragraph>
                  <paragraph/>
                  <paragraph/>
                  <paragraph/>
                  <paragraph>
                     <content styleCode="bold">ABLYSINOLÂ® (Dehydrated Alcohol Injection, USP)</content>
                     <br/>
                     <content styleCode="bold">NDC 54288-105-15</content>
                     <br/>
                     <content styleCode="bold">5mL - AMPULE - CARTON - 10 PACK</content>
                  </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="L0ba64136-67de-4d3d-9ad2-b3e239277235"/>
                  </paragraph>
                  <paragraph/>
                  <paragraph/>
                  <paragraph/>
               </text>
               <effectiveTime value="20250317"/>
               <component>
                  <observationMedia ID="La439e64f-120d-41f9-ae7a-ea67c5c19fc1">
                     <text>5mL ampul label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Ablysinol_5ml_label.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="L0ba64136-67de-4d3d-9ad2-b3e239277235">
                     <text>5 mL Ampule Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Ablysinol_5ml_carton.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="L25267983-53a7-4735-a3f6-15020cb3e7c2">
               <id root="a03a2d8d-45e8-4448-ae41-2376c8eaacc3"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL - 5 mL VIAL</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">ABLYSINOLÂ® (Dehydrated Alcohol Injection, USP)</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">NDC 54288-144-01</content>
                     <br/>
                     <content styleCode="bold">5 mL - VIAL - LABEL</content>
                  </paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="Lfb7d66ef-ea4f-41bd-98e3-54b12de62bf0"/>
                  </paragraph>
                  <paragraph/>
                  <paragraph/>
                  <paragraph>
                     <content styleCode="bold">ABLYSINOLÂ® (Dehydrated Alcohol Injection, USP)</content>
                     <br/>
                     <content styleCode="bold">NDC 54288-144-10</content>
                     <br/>
                     <content styleCode="bold">5 mL - VIAL - CARTON - 10 PACK</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <renderMultiMedia referencedObject="Lfc67d1df-e0e7-44d0-99dd-5ddf105fc477"/>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold"/>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold"/>
                  </paragraph>
               </text>
               <effectiveTime value="20250317"/>
               <component>
                  <observationMedia ID="Lfb7d66ef-ea4f-41bd-98e3-54b12de62bf0">
                     <text>5 mL Vial Label</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Ablysinol Label v2 5ml R2503-3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="Lfc67d1df-e0e7-44d0-99dd-5ddf105fc477">
                     <text>5 mL Vial Carton</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="Ablysinol Carton 130mg 10pk New Size R2503-1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>